StockEdge: Stock Analysis, Screening & Research Platform for India
Depends
Confidence: Low
Active Indian retail traders who do daily EOD research fit this well . scans, F&O analytics, and Edge reports are the draw.
Comparison
StockEdge: Stock Analysis, Screening & Research Platform for India and Chartink both land on Depends.
Active Indian retail traders who do daily EOD research fit this well . scans, F&O analytics, and Edge reports are the draw.
Buy if you actively trade Indian NSE/BSE stocks and want a deep, customizable screener with a usable free tier.
| Compare | StockEdge: Stock Analysis, Screening & Research Platform for India | Chartink |
|---|---|---|
| Verdict | Depends | Depends |
| Best for | Active Indian stock traders | Indian intraday traders |
| Who it's not for | Passive index-fund investors . a screener is overkill | US or global market traders . no US data |
| Privacy | No known public vulnerabilities found in the sources reviewed.² | No known public vulnerabilities found in the sources reviewed.13 |
| Support quality | No support evidence in sources reviewed. | Reviews mixed; praise and 'pathetic service' complaints coexist |
| Public sentiment | Praise for scans and derivative analytics exists, but every quote is vendor-published with no independent sources.¹ | Indian traders widely praise the screener's power but report delayed free data, latency on alerts, mixed support, and no US-market coverage.⁷ |
| Biggest gotcha | Pricing not visible on reviewed pages; confirm plan costs in-app before subscribing.¹ | Free tier lags ~5 minutes; some scanners flag stocks already up 4-5%⁸ |